دورية أكاديمية

Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial.

التفاصيل البيبلوغرافية
العنوان: Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial.
المؤلفون: Ping-I Hsu, John Y., Kuan-Yang Chen, Wei-Chen Tai, Jyh-Chin Yang, Feng-Woei Tsay, Yu-Hwa Liu, Chien-Lin Chen, Chia-Long Lee, Hong-Zen Yeh, Chao-Hung Kuo, Seng-Kee Chuah, Hsi-Chang Lee, Chang-Bih Shie, Sz-Iuan Shiu, Kao, John Y., Yoshio Yamaoka, Graham, David Y., Deng-Chyang Wu
المصدر: American Journal of Gastroenterology (Lippincott Williams & Wilkins); Jul2023, Vol. 118 Issue 7, p1184-1195, 12p
قاعدة البيانات: Complementary Index
الوصف
تدمد:00029270
DOI:10.14309/ajg.0000000000002255